A pharmacokinetic study of midazolam in prostate cancer patients and patients with solid tumours: in vivo phenotyping of CYP3A
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Externe beoordelaar - External assesor, | |
dc.contributor.author | Ribbers, Claire | |
dc.date.accessioned | 2023-12-07T00:01:02Z | |
dc.date.available | 2023-12-07T00:01:02Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/45611 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | Fenotyperen van CYP3A4 in patienten met prostaatkanker en mannelijke patiënten met andere soorten tumoren. Fenotypering is uitgevoerd met midazolam. Met de farmacokinetische midazolam data is een NCA uitgevoerd. | |
dc.title | A pharmacokinetic study of midazolam in prostate cancer patients and patients with solid tumours: in vivo phenotyping of CYP3A | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Pharmacy | |
dc.thesis.id | 26338 |